Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy now. On July 10, Morgan Stanley analyst Terrence Flynn reiterated a hold rating on Pfizer Inc. (NYSE:PFE), setting a $32 price ...

Morgan Stanley (NYSE:MS) on Wednesday reported a second-quarter 2025 earnings of $2.13, up from $1.82 a year ago and beating ...

Amicus Therapeutics (FOLD) stock gains as Morgan Stanley upgrades, citing a favorable patent dispute setup and potential for its Pompe disease therapy. Read more here.

Morgan Stanley's Single Family Office Advisory today released its biennial compensation report. The 2025 report, created in ...

The Wall Street powerhouse has built its wealth division in large part through big deals but is not "looking to make ...

We view Morgan Stanley's strategic approach as appropriate as it effectively leverages the firm's strengths in wealth management and investment banking and trading. The firm's business has evolved ...

Executives at the New York bank said that strategic activity has started to pick up over the last month. Morgan Stanley also ...

Morgan Stanley Chief Executive Officer Ted Pick said “the tide may begin to shift” in the ocean of private credit.

The Wall Street bank is evaluating opportunities that fit into its strategy, Pick told analysts who quizzed him on a ...

Atlanta-based CoastalSouth's initial public offering prices at $21.50 a share; Valley National Bancorp announces Lyndsey ...

A new tool at Morgan Stanley has saved more than 11,000 days of work this year alone and replaced "onerous" rote work.

Morgan Stanley’s scale on both the high end and low end of the market offers a competitive advantage that allows it to stay at the top, Mackenzie said.